A new digital health tool has been approved by the U.S. Food and Drug Administration. The approval of the iOS-compatible application will enable individuals with chronic pain and movement disorders to receive personalized therapy through their mobile device. Abbott can now move forward with the Patient Controller app on compatible personal Apple smartphone devices and eliminate the need to carry a separate patient programmer device to streamline the therapeutic experience and seamlessly integrate therapy management. Full story.